Hand-Foot-Syndrome (Hfs) Is A Strong Predictor For Os And Pfs In Her2-Negative Metastatic Breast Cancer (Mbc) Treated With First-Line Capecitabine (Cap) Plus Bevacizumab (Bev): Results Of A Subanalysis Of The Randomized Phase Iii Cecog Turandot Trial
CANCER RESEARCH（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined